Events

BioStock Live features the Swedish medtech company Acarix. CEO, Per Persson, gives an update about the company and its product, the CADScor System. Acarix has recently received market approval for CADScor in the US, and the CEO expects a news-intensive 2021.

 

https://www.biostock.se/2021/04/biostock-live-with-acarix/

 

 

About Acarix
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.